Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Non-Current Assets (2019 - 2025)

AVITA Medical (RCEL) has disclosed Other Non-Current Assets for 5 consecutive years, with $612000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 12.09% year-over-year to $612000.0, compared with a TTM value of $612000.0 through Dec 2025, up 12.09%, and an annual FY2025 reading of $612000.0, up 12.09% over the prior year.
  • Other Non-Current Assets was $612000.0 for Q4 2025 at AVITA Medical, down from $1.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.1 million in Q3 2025 and bottomed at $201000.0 in Q1 2022.
  • Average Other Non-Current Assets over 4 years is $548111.1, with a median of $546000.0 recorded in 2024.
  • Peak annual rise in Other Non-Current Assets hit 96.7% in 2025, while the deepest fall reached 12.09% in 2025.
  • Year by year, Other Non-Current Assets stood at $201000.0 in 2022, then soared by 76.62% to $355000.0 in 2023, then skyrocketed by 53.8% to $546000.0 in 2024, then increased by 12.09% to $612000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for RCEL at $612000.0 in Q4 2025, $1.1 million in Q3 2025, and $839000.0 in Q2 2025.